APA (7th ed.) Citation

X, H., S, J., & X, L. (2024). Site-specific or empirical chemotherapy for cancer of unknown primary: The right answer? - Authors' reply. The Lancet. Oncology, 25(11), e530. https://doi.org/10.1016/S1470-2045(24)00569-2

Chicago Style (17th ed.) Citation

X, Hu, Jiang S, and Liu X. "Site-specific or Empirical Chemotherapy for Cancer of Unknown Primary: The Right Answer? - Authors' Reply." The Lancet. Oncology 25, no. 11 (2024): e530. https://doi.org/10.1016/S1470-2045(24)00569-2.

MLA (9th ed.) Citation

X, Hu, et al. "Site-specific or Empirical Chemotherapy for Cancer of Unknown Primary: The Right Answer? - Authors' Reply." The Lancet. Oncology, vol. 25, no. 11, 2024, p. e530, https://doi.org/10.1016/S1470-2045(24)00569-2.